Jazz Pharmaceuticals Announces Full Year And Fourth Quarter 2017 Financial Results
Go back to Jazz Pharmaceuticals Announces Full Year And Fourth Quarter 2017 Financial Results| JAZZ PHARMACEUTICAL (NASDAQ: JAZZ) | Delayed: 243.59 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $243.59 | 52 Week High | $160.00 | |||
| Open | $243.59 | 52 Week Low | $95.80 | |||
| Day High | $243.59 | P/E | 45.28 | |||
| Day Low | $243.59 | EPS | $5.38 | |||
| Volume | 2,701 | |||||
